Featured in Chicago Booth Magazine: Med-Tech and Real Estate Ventures Find Pre-Seed Success

We're proud to be featured in Chicago Booth Magazine's spring Startup Spotlight, which profiles four Polsky Center ventures gathering momentum at different funding stages. The piece highlights Theta Neurotech alongside Beacon, Unlisted, and OrisDX, tracing our path from the College New Venture Challenge through the Launch Accelerator, the $200,000 George Shultz Innovation Fund finals check, and into our pre-seed round.

The article also notes our early presence at Hyde Park Labs and the UChicago Science Incubator, and looks ahead to our pilot clinical study at UChicago Medicine and our work with the FDA to clarify the regulatory pathway. We're grateful to the Polsky Center and the broader UChicago ecosystem for the continued support.

Read the full article →

Previous
Previous

Featured in MedTech Innovator: Theta Selected for 2026 Accelerator Cohort and Inaugural MTI Index

Next
Next

Featured in Smithsonian Magazine: These Young Innovators Have Created a 'Fitbit' to Predict Epileptic Seizures